Search research articles
Contact Us
Filters
Showing results (251-260 of 291) with videos related to
Page
of 30
Sort By:
NPJ Vaccines
|
December 17, 2019
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts
Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, et al.
Nature Communications
|
October 12, 2017
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice
Wenqian He, Chi-Jene Chen, Caitlin E Mullarkey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 17, 2021
Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes
Alec W Freyn, Julianna Han, Jenna J Guthmiller, et al.
Ebiomedicine
|
June 7, 2024
Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice
Stefan Slamanig, Irene González-Domínguez, Lauren A Chang, et al.
The Journal of Clinical Investigation
|
February 18, 2015
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains
Carole J Henry Dunand, Paul E Leon, Kaval Kaur, et al.
NPJ Vaccines
|
September 19, 2024
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity
Raveen Rathnasinghe, Lauren A Chang, Rebecca Pearl, et al.
Science Translational Medicine
|
December 4, 2015
Immune history profoundly affects broadly protective B cell responses to influenza
Sarah F Andrews, Yunping Huang, Kaval Kaur, et al.
Nature
|
September 18, 2012
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Damian C Ekiert, Arun K Kashyap, John Steel, et al.
The Lancet. Infectious Diseases
|
April 24, 2022
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial
Nicolas Folschweiller, Carline Vanden Abeele, Laurence Chu, et al.
Cell Host & Microbe
|
June 10, 2016
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
Carole J Henry Dunand, Paul E Leon, Min Huang, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 291) with videos related to
Sort By:
Page
of 30
NPJ Vaccines
|
December 17, 2019
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts
Raffael Nachbagauer, Bruno Salaun, Daniel Stadlbauer, et al.
Nature Communications
|
October 12, 2017
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice
Wenqian He, Chi-Jene Chen, Caitlin E Mullarkey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 17, 2021
Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes
Alec W Freyn, Julianna Han, Jenna J Guthmiller, et al.
Ebiomedicine
|
June 7, 2024
Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice
Stefan Slamanig, Irene González-Domínguez, Lauren A Chang, et al.
The Journal of Clinical Investigation
|
February 18, 2015
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains
Carole J Henry Dunand, Paul E Leon, Kaval Kaur, et al.
NPJ Vaccines
|
September 19, 2024
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity
Raveen Rathnasinghe, Lauren A Chang, Rebecca Pearl, et al.
Science Translational Medicine
|
December 4, 2015
Immune history profoundly affects broadly protective B cell responses to influenza
Sarah F Andrews, Yunping Huang, Kaval Kaur, et al.
Nature
|
September 18, 2012
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Damian C Ekiert, Arun K Kashyap, John Steel, et al.
The Lancet. Infectious Diseases
|
April 24, 2022
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial
Nicolas Folschweiller, Carline Vanden Abeele, Laurence Chu, et al.
Cell Host & Microbe
|
June 10, 2016
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
Carole J Henry Dunand, Paul E Leon, Min Huang, et al.
Page
of 30